Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity. [electronic resource] by
- Koleini, Navid
- Santiago, Jon-Jon
- Nickel, Barbara E
- Sequiera, Glen Lester
- Wang, Jie
- Fandrich, Robert R
- Jassal, Davinder S
- Dhingra, Sanjiv
- Kirshenbaum, Lorrie A
- Cattini, Peter A
- Kardami, Elissavet
Producer: 20191227
In:
American journal of physiology. Heart and circulatory physiology vol. 316
Availability: No items available.
|
|
13.
|
High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling. [electronic resource] by
- Santiago, Jon-Jon
- McNaughton, Leslie J
- Koleini, Navid
- Ma, Xin
- Bestvater, Brian
- Nickel, Barbara E
- Fandrich, Robert R
- Wigle, Jeffrey T
- Freed, Darren H
- Arora, Rakesh C
- Kardami, Elissavet
Producer: 20150105
In:
PloS one vol. 9
Availability: No items available.
|
|
14.
|
Calreticulin induces dilated cardiomyopathy. [electronic resource] by
- Lee, Dukgyu
- Oka, Tatsujiro
- Hunter, Beth
- Robinson, Alison
- Papp, Sylvia
- Nakamura, Kimitoshi
- Srisakuldee, Wattamon
- Nickel, Barbara E
- Light, Peter E
- Dyck, Jason R B
- Lopaschuk, Gary D
- Kardami, Elissavet
- Opas, Michal
- Michalak, Marek
Producer: 20130821
In:
PloS one vol. 8
Availability: No items available.
|